Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Neoplasms, Male × Chemotherapy, Adjuvant × Clear all

Phase

Phase 2 5 Phase NA 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Colorectal Neoplasms 11 Colonic Neoplasms 11 Rectal Neoplasms 9 Prostatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Stomach Neoplasms 5 Head and Neck Neoplasms 5 Endometrial Neoplasms 5 Central Nervous System Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Melanoma 4 Lung Neoplasms 4 Kidney Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Sarcoma 3 Neuroblastoma 3 Liver Neoplasms 3 Gallbladder Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Hepatocellular 3 Bile Duct Neoplasms 3 Salivary Gland Neoplasms 2 Pancreatic Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Renal Cell 2

Interventions

exemestane 3 Paclitaxel 3 Goserelin 3 pegfilgrastim 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Cyclophosphamide 2 trastuzumab biosimilar HLX02 1 ribociclib 1 Zoledronic Acid 1 Trastuzumab 1 Taxes 1 Radiotherapy 1 Radiosurgery 1 Pyridoxine 1 Prochlorperazine 1 Palonosetron 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Methotrexate 1 Metformin 1 Lapatinib 1 Ibandronic Acid 1 Granisetron 1 Gonadotropin-Releasing Hormone 1 Fluorouracil 1 Fentanyl 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00301925 2018-08-08

TACT2

Institute of Cancer Research, United Kingdom

Phase 3 Unknown

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡